Article Text

Download PDFPDF
Antinuclear antibody and HLA-B27 positive uveitis: combination of two diseases?
  1. E H Bosch-Driessena,
  2. N M Lardyb,
  3. A Rothovaa
  1. aDepartment of Ophthalmology, F C Donders Institute, Academic Hospital Utrecht, Utrecht, Netherlands, bDepartment of HLA Diagnostics, Central Laboratory of the Netherlands Red-Cross Blood Transfusion Service, Amsterdam, Netherlands
  1. E H Bosch-Driessen, Department of Ophthalmology, Academic Hospital Utrecht, E 03. 136, Heidelberglaan 100, 3584 CX Utrecht, Netherlands.

Abstract

AIMS/BACKGROUND Anterior uveitis associated with juvenile chronic arthritis concerns two different clinical entities: firstly, antinuclear antibody (ANA) positive patients who have a chronic anterior uveitis with severe complications and often a poor visual prognosis; secondly, usually HLA-B27 positive children, predominantly boys, with unilateral recurrent anterior uveitis. Three patients are described who had a combination of clinical and laboratory features of both diseases.

METHODS Retrospective clinical and laboratory analysis of three patients.

RESULTS Ocular features in the three patients combined the clinical picture of ANA positive chronic anterior uveitis during early childhood with the clinical features of HLA-B27 unilateral acute anterior uveitis during adolescence. The patients fulfilled the diagnostic criteria of juvenile chronic arthritis, and they had no ankylosing spondylitis. All three patients had the HLA-B*2705 subtype.

CONCLUSIONS Whether the association of ANA positive chronic anterior uveitis and HLA-B27 unilateral acute anterior uveitis is a coincidence or represents a distinct clinical entity is not yet clear.

  • antinuclear antibody
  • HLA-B27
  • uveitis
  • juvenile chronic arthritis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes